Investor Relations


“This was undoubtedly a very challenging year for the business.  Following margin pressure in the first half we took decisive action to address the internal issues and mitigate the external factors we faced.  We are on track to restore margins during this autumn to the levels previously enjoyed."


“The global healthcare market has proved resilient during the economic downturn and demand for our services generally remains strong driven by demographic trends, regulatory pressures and government spending commitments.  We opened new sites in the period and are close to completing new facilities in the UK, Europe and, most importantly, China.  These new sites will drive organic growth rates in the coming years."


“Following a period characterised by acquisitions and significant investment in new facilities, the immediate future will focus on realising the benefits of these investments, in particular Synergy’s strong cash generation which will be used to reduce net debt.  The strategy remains to enter new health-related markets, expand into new European territories and develop a significant presence in the fast-growing Asian markets.  We expect the imminent opening of our first facility in China to mark the start of a period of strong growth from this region and we are confident that Synergy will continue to prosper in the year ahead.”


Dr Richard Steeves, Chief Executive
Excerpt from the Preliminary Results for the Year Ended 29 March 2009.


Check Synergy Health's latest share price on the London Stock Exchange website.